Jennison Associates’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-210,186
Closed -$25.9M 612
2023
Q4
$25.9M Sell
210,186
-260,413
-55% -$32.5M 0.02% 302
2023
Q3
$60.9M Buy
470,599
+14,581
+3% +$1.94M 0.05% 155
2023
Q2
$56.5M Buy
456,018
+4,753
+1% +$639K 0.05% 175
2023
Q1
$66M Sell
451,265
-10,848
-2% -$1.6M 0.06% 151
2022
Q4
$73.6M Buy
462,113
+16,352
+4% +$2.4M 0.07% 140
2022
Q3
$59.4M Buy
445,761
+136,361
+44% +$20.7M 0.06% 156
2022
Q2
$48.3M Buy
309,400
+175,916
+132% +$27.1M 0.05% 174
2022
Q1
$20.8M Buy
133,484
+26,253
+24% +$3.81M 0.02% 347
2021
Q4
$13.7M Buy
107,231
+2,041
+2% +$268K 0.01% 418
2021
Q3
$13.7M Sell
105,190
-240,716
-70% -$36.4M 0.01% 415
2021
Q2
$61.4M Buy
345,906
+107,834
+45% +$18.7M 0.04% 186
2021
Q1
$39.1M Buy
238,072
+37,105
+18% +$6.11M 0.03% 252
2020
Q4
$33.2M Buy
+200,967
New +$29.9M 0.02% 279
2020
Q1
Sell
-4,176
Closed -$623K 664
2019
Q4
$623K Buy
+4,176
New +$568K ﹤0.01% 575
2019
Q1
Sell
-4,245
Closed -$526K 666
2018
Q4
$526K Buy
+4,245
New +$630K ﹤0.01% 606
2016
Q4
Sell
-56,937
Closed -$6.92M 821
2016
Q3
$6.92M Sell
56,937
-549,083
-91% -$74M 0.01% 494
2016
Q2
$85.6M Sell
606,020
-54,058
-8% -$7.97M 0.09% 196
2016
Q1
$86.2M Sell
660,078
-3,468
-0.5% -$432K 0.09% 190
2015
Q4
$93.3M Sell
663,546
-109,117
-14% -$15.1M 0.09% 182
2015
Q3
$103M Sell
772,663
-3,697
-0.5% -$637K 0.11% 173
2015
Q2
$137M Sell
776,360
-78,988
-9% -$14.2M 0.13% 149
2015
Q1
$148M Sell
855,348
-87,825
-9% -$15.1M 0.14% 142
2014
Q4
$154M Buy
943,173
+119,817
+15% +$19.9M 0.14% 133
2014
Q3
$132M Sell
823,356
-324,740
-28% -$49.9M 0.12% 155
2014
Q2
$169M Buy
1,148,096
+171,883
+18% +$23.8M 0.16% 134
2014
Q1
$135M Buy
+976,213
New +$147M 0.13% 154

Other funds holding JAZZ